Research graph
References from Hyponatremia After CAR T-Cell Therapy: Biomarker or Therapeutic Target?. Local targets link to admitted publications; unresolved targets remain external evidence.
The Association Between Hyponatremia and Immune Effector Cell-Associated Neurotoxicity Syndrome After Chimeric Antigen Receptor T Cell Therapy
2026 · External reference
Frontal intermittent rhythmic delta activity is a useful diagnostic tool of neurotoxicity after CAR T-cell infusion
2023 · External reference
Correlation of IL-6 secretion and hyponatremia with the use of CD19+ chimeric antigen receptor T-cells
10.5414/cn109872 · 2020 · External reference
Clinical practice guideline on diagnosis and treatment of hyponatraemia
10.1530/eje-13-1020 · 2014 · External reference
Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations
10.1016/j.amjmed.2013.07.006 · 2013 · External reference
ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
10.1016/j.bbmt.2018.12.758 · 2019 · External reference
Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline
10.1200/jco.21.01992 · 2021 · External reference
Diagnosis and management of hyponatremia: a review
10.1001/jama.2022.11176 · 2022 · External reference
Osmotic demyelination syndrome following correction of hyponatremia
10.1056/nejm198606123142402 · 1986 · External reference
Treatment guidelines for hyponatremia: stay the course
10.2215/cjn.0000000000000244 · 2024 · External reference
